Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017)

Por Liu, Albert Y., Norwood, Aliza, Gundacker, Holly, Carballo-Diéguez, Alex, Johnson, Sherri, Patterson, Karen, Bekker, Linda-Gail, Chariyalertsak, Suwat, Chitwarakorn, Anupong, Gonzales, Pedro, Holtz, Timothy H., Mayer, Kenneth H., Zorrilla, Carmen, Buchbinder, Susan, Piper, Jeanna M., Lama, Javier R., Cranston, Ross D.
Publicado no J Acquir Immune Defic Syndr (2019)